Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Monthly Care Management Payments Called “Win-Win-Win” Reform
Read More
Enhanced Reimbursement for Oncology Services Pays for Patient-Centered Care
Read More
Bundling Payments: UnitedHealthcare Dips a Toe in the Water
Read More
The Push Toward Value-Based Payment for Oncology
Read More
In the Literature
Read More
ASCO and NCI Launch Largest Precision Medicine Trials Using Real-World Evidence
Read More
Genetic Abnormality Pinpointed for Intensive Therapy in Wilms Tumor
Read More
Urine Biopsies Detect Early Mutations in Patients with Advanced Cancers
Read More
Leukemia
,
Oncology
Adding Ibrutinib to Standard Therapy Reduces Disease Progression by 80% in Previously Treated Patients with CLL
Read More
Leukemia
,
Oncology
Adherence to Ibrutinib Therapy Improves Outcomes in Patients with CLL
Read More
127
128
129
130
131
132
133
Page 130 of 244
Results 1291 - 1300 of 2434